This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Hajime Hirao: Innovator in Cathepsin S Inhibition
Introduction
Hajime Hirao is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as inhibitors for cathepsin S. His work is crucial in advancing therapeutic options for various diseases.
Latest Patents
Hirao holds a patent for "Compounds and compositions useful as cathepsin S inhibitors." This invention relates to the use of a 2-cyanopyrimidine compound, which has potential applications in treating conditions associated with cathepsin S activity. He has 1 patent to his name, showcasing his innovative approach to drug development.
Career Highlights
Throughout his career, Hajime Hirao has been associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in pharmaceuticals.
Collaborations
Hirao has worked alongside notable colleagues such as Fumiaki Yokokawa and Masashi Kishida. Their combined expertise has fostered an environment of innovation and discovery, leading to advancements in their respective fields.
Conclusion
Hajime Hirao's contributions to the field of medicinal chemistry, particularly through his patent on cathepsin S inhibitors, highlight his role as a key innovator. His work continues to influence the development of new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile